SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014266
Filing Date
2023-08-09
Accepted
2023-08-09 16:15:29
Documents
45
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q tmb-20230630x10q.htm   iXBRL 10-Q 1001795
2 EX-31.1 tmb-20230630xex31d1.htm EX-31.1 16120
3 EX-31.2 tmb-20230630xex31d2.htm EX-31.2 15499
4 EX-32.1 tmb-20230630xex32d1.htm EX-32.1 8276
5 EX-32.2 tmb-20230630xex32d2.htm EX-32.2 8209
  Complete submission text file 0001558370-23-014266.txt   3774884

Data Files

Seq Description Document Type Size
6 EX-101.SCH tmb-20230630.xsd EX-101.SCH 25031
7 EX-101.CAL tmb-20230630_cal.xml EX-101.CAL 18372
8 EX-101.DEF tmb-20230630_def.xml EX-101.DEF 99961
9 EX-101.LAB tmb-20230630_lab.xml EX-101.LAB 260505
10 EX-101.PRE tmb-20230630_pre.xml EX-101.PRE 191349
39 EXTRACTED XBRL INSTANCE DOCUMENT tmb-20230630x10q_htm.xml XML 496380
Mailing Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024
Business Address 1 BRIDGE PLAZA, SUITE 275 FORT LEE NJ 07024 360-837-7232
Nuvectis Pharma, Inc. (Filer) CIK: 0001875558 (see all company filings)

IRS No.: 862405608 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41264 | Film No.: 231155352
SIC: 2834 Pharmaceutical Preparations